Nevertheless, the observation made here that GBM cells with a lower TDP1/TOP1 activity ratio would be more sensitive to the TOP1 poison inhibitor is valid with the GBM CES activity data being taken into consideration. The gene discussed is TDP1; the disease is glioblastoma.